Viewing Study NCT01096667


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2025-12-28 @ 2:06 PM
Study NCT ID: NCT01096667
Status: COMPLETED
Last Update Posted: 2018-09-13
First Post: 2010-03-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)
Sponsor: Merck Sharp & Dohme LLC
Organization: